Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
Verstovsek S, Foltz L, Gupta V, Hasserjian R, Manshouri T, Mascarenhas J, Mesa R, Pozdnyakova O, Ritchie E, Veletic I, Gamel K, Hamidi H, Han L, Higgins B, Trunzer K, Uguen M, Wang D, El-Galaly TC, Todorov B, Gotlib J. Verstovsek S, et al. Among authors: pozdnyakova o. Haematologica. 2023 Oct 1;108(10):2730-2742. doi: 10.3324/haematol.2022.282411. Haematologica. 2023. PMID: 37165840 Free PMC article. Clinical Trial.
Say hello to TUGSE!
Wright KT, Pozdnyakova O. Wright KT, et al. Among authors: pozdnyakova o. Blood. 2019 Oct 17;134(16):1360. doi: 10.1182/blood.2019002505. Blood. 2019. PMID: 31698439 Free article. No abstract available.
Anti-DNA autoreactivity in C4-deficient mice.
Paul E, Pozdnyakova OO, Mitchell E, Carroll MC. Paul E, et al. Among authors: pozdnyakova oo. Eur J Immunol. 2002 Sep;32(9):2672-9. doi: 10.1002/1521-4141(200209)32:9<2672::AID-IMMU2672>3.0.CO;2-X. Eur J Immunol. 2002. PMID: 12207352 Free article.
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy.
Mugoni V, Panella R, Cheloni G, Chen M, Pozdnyakova O, Stroopinsky D, Guarnerio J, Monteleone E, Lee JD, Mendez L, Menon AV, Aster JC, Lane AA, Stone RM, Galinsky I, Zamora JC, Lo-Coco F, Bhasin MK, Avigan D, Longo L, Clohessy JG, Pandolfi PP. Mugoni V, et al. Among authors: pozdnyakova o. Cell Res. 2019 Jun;29(6):446-459. doi: 10.1038/s41422-019-0162-7. Epub 2019 Apr 25. Cell Res. 2019. PMID: 31024166 Free PMC article.
Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.
Kats LM, Reschke M, Taulli R, Pozdnyakova O, Burgess K, Bhargava P, Straley K, Karnik R, Meissner A, Small D, Su SM, Yen K, Zhang J, Pandolfi PP. Kats LM, et al. Among authors: pozdnyakova o. Cell Stem Cell. 2014 Mar 6;14(3):329-41. doi: 10.1016/j.stem.2013.12.016. Epub 2014 Jan 16. Cell Stem Cell. 2014. PMID: 24440599 Free PMC article.
CD99 - much ado about nothing?
Pozdnyakova O, Mahalingam M. Pozdnyakova O, et al. J Cutan Pathol. 2008 Jan;35(1):86-7. doi: 10.1111/j.1600-0560.2007.00776.x. J Cutan Pathol. 2008. PMID: 18096002 No abstract available.
Germline NPM1 mutations lead to altered rRNA 2'-O-methylation and cause dyskeratosis congenita.
Nachmani D, Bothmer AH, Grisendi S, Mele A, Bothmer D, Lee JD, Monteleone E, Cheng K, Zhang Y, Bester AC, Guzzetti A, Mitchell CA, Mendez LM, Pozdnyakova O, Sportoletti P, Martelli MP, Vulliamy TJ, Safra M, Schwartz S, Luzzatto L, Bluteau O, Soulier J, Darnell RB, Falini B, Dokal I, Ito K, Clohessy JG, Pandolfi PP. Nachmani D, et al. Among authors: pozdnyakova o. Nat Genet. 2019 Oct;51(10):1518-1529. doi: 10.1038/s41588-019-0502-z. Epub 2019 Sep 30. Nat Genet. 2019. PMID: 31570891 Free PMC article.
Sysmex XE-5000 blast Q flag analysis.
Pozdnyakova O, Dorfman DM. Pozdnyakova O, et al. Am J Clin Pathol. 2013 Dec;140(6):918-9. doi: 10.1309/AJCPCTKEU7IVW6IP. Am J Clin Pathol. 2013. PMID: 24225762 No abstract available.
119 results